Kyle Malady, Director: Dexcom DXCM Planned sale · Filed 25/09/05

Trade details

Type: Planned sale notice
Stock: Dexcom DXCM
Person: Kyle MaladyDirector
Planned sale date: 25/09/05
Filed: 25/09/05

$53.9K to be sold

Dexcom trades, last 26 weeks

What else happened in Dexcom around then

Filed or reported within 30 days of the trade day · 25/08/06~25/10/05

Kyle Malady's recent trades

Kyle MaladyEVP and Group CEO-VZ Business
Sell10b5-1 planVerizon Communications
Sell10b5-1 plan
Verizon Communications
VZ
$51K
1,100 sh
$51K
Filed 09/30
Traded 09/29
Kyle MaladyEVP and Group CEO-VZ Business
Planned sale10b5-1 planVerizon Communications
Planned sale10b5-1 plan
Verizon Communications
VZ
$51K
1,100 sh
$51K
Filed 09/29
Traded 09/29
Kyle MaladyEVP and Group CEO-VZ Business
Sell10b5-1 planVerizon Communications
Sell10b5-1 plan
Verizon Communications
VZ
$52.4K
1,100 sh
$52.4K
Filed 09/23
Traded 09/22
Kyle MaladyEVP and Group CEO-VZ Business
Planned sale10b5-1 planVerizon Communications
Planned sale10b5-1 plan
Verizon Communications
VZ
$52.4K
1,100 sh
$52.4K
Filed 09/22
Traded 09/22
Kyle MaladyEVP and Group CEO-VZ Business
Planned sale10b5-1 planVerizon Communications
Planned sale10b5-1 plan
Verizon Communications
VZ
$56.3K
1,100 sh
$56.3K
Filed 09/15
Traded 09/15

Kyle Malady, Director — plans to sell 667 sh of Dexcom DXCM · $53.9K · around 09/05 · 10b5-1 plan | Whalegun